ReviewInfectious diseases and therapy2014

Safety and Effectiveness of Palivizumab in Children at High Risk of Serious Disease Due to Respiratory Syncytial Virus Infection: A Systematic Review.

Colleen Wegzyn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.